Altered Gemcitabine and Nab-paclitaxel Scheduling Improves Therapeutic Efficacy Compared with Standard Concurrent Treatment in Preclinical Models of Pancreatic Cancer

Added 248 days ago (19.01.2021)
Authors: Wolfe, A. R., Robb, R., Hegazi, A., Abushahin, L., Yang, L., Shyu, D.-L., Trevino, J. G., Cruz-Monserrate, Z., Jacob, J. R., Palanichamy, K., Chakravarti, A., Williams, T. M.
Read article